Nurix Therapeutics NRIX
NASDAQ NRIX
$25.49 -0.53 (-2.04%)
As of: Oct 22, 2026 · 2:45 PM EDT

Nurix Therapeutics (NRIX) FCF Margin (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) reported FCF Margin of 91.26% for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 852.55 percentage points from -761.29% a year earlier and up 1180.60 percentage points from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) FCF Margin (2019 - 2026) Analysis & Trends

Over the twelve months ended Aug 31, 2026, Nurix Therapeutics' FCF Margin came in at 52.68%, up 341.09 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it came in at -313.73%, up 19.66 percentage points from FY2024.

  • FCF Margin has a five-year change of -287.73 percentage points (FY2020 to FY2025).
  • By fiscal year, FCF Margin came in at -333.38% in FY2024 (-216.78 pp), -116.60% in FY2023 (+328.82 pp), -445.42% in FY2022 (-142.81 pp) and -302.61% in FY2021 (-276.61 pp).
  • The fiscal Q3 2026 figure ranks as the highest quarterly FCF Margin since fiscal Q4 2023.
  • Year over year, FCF Margin gained in two of the last eight quarters, with an average year-over-year change of -236.63 percentage points.
  • The high point for year-over-year FCF Margin in five years was fiscal Q3 2026 (a gain of 852.55 percentage points); the low point was fiscal Q2 2026 (a drop of 939.90 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -1089.34% (Q2 2026), -1166.97% (Q1 2026) and -537.40% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,166.05 Bn 1,134.64 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 647.70 Bn 567.56 Bn 17.30 Bn 25.03%
3 AbbVie 503.26 Bn 476.37 Bn 12.70 Bn 18.33%
4 Merck 366.29 Bn 320.67 Bn 12.21 Bn 26.96%
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 38.60%
6 Astrazeneca 268.96 Bn 242.64 Bn 12.86 Bn 6.55%
7 Amgen 242.14 Bn 197.54 Bn 7.24 Bn 34.70%
8 Gilead Sciences 194.83 Bn 169.02 Bn 6.22 Bn 44.00%
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 2.01%
10 Nurix Therapeutics 2.85 Bn 223.86 Mn - 91.26%
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 91.26%
May 31, 2026 -1,089.34%
Feb 28, 2026 -1,166.97%
Nov 30, 2025 -537.40%
Aug 31, 2025 -761.29%
May 31, 2025 -149.44%
Feb 28, 2025 -349.93%
Nov 30, 2024 -382.84%
Aug 31, 2024 -353.70%
May 31, 2024 -344.38%
Feb 29, 2024 -270.33%
Nov 30, 2023 159.01%
Aug 31, 2023 -236.05%
May 31, 2023 -63.73%
Feb 28, 2023 -399.91%
Nov 30, 2022 -597.38%
Aug 31, 2022 -460.81%
May 31, 2022 -312.31%
Feb 28, 2022 -479.18%
Nov 30, 2021 -429.60%
API Access

Nurix Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY